Google NewsHow Is Vitura Health (ASX:VIT) Wiring Cannabis and Psychedelics? - Kalkine Media
How Is Vitura Health (ASX:VIT) Wiring Cannabis and Psychedelics? Kalkine Media
VIT
Health Care Equipment & Services
Vitura Health
- Short interest
- 0.00%
- −0.01 pp 30d
- as of 14 Feb 2025
- Reported shorts
- 5.2K
- Shares on issue
- 656.468M
Vitura Health (VIT) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Vitura Health (ASX:VIT) EBITDA Jumps 197% as Turnaround Starts to Take Shape - Stocks Down Under
Vitura Health (ASX:VIT) EBITDA Jumps 197% as Turnaround Starts to Take Shape Stocks Down Under
ASX
KalkineHow Exposed Is Vitura Health (ASX:VIT) After Bupa's Shift?
Highlights Bupa will move international members to a rival telehealth platform. Vitura has issued a breach notice and still guides to a stronger year. Its cannabis distribution arm is the other pillar of the story. Vitura Health (ASX:VIT), the Melbourne-based digital health and medicinal cannabis group, has disclosed a material setback for its Doctors on Demand telehealth unit after insurer Bupa Australia decided to move its international members to rival platform Hola Health. The group says ...
Commencement of Chief Financial Officer
other announcement
Why Does the Bupa Dispute Loom Over Vitura Health (ASX:VIT)?
Highlights Annual meeting date set as a key insurer contract unravels Telehealth arm loses a large block of referred patients Cannabis distribution platform remains the group's anchor Vitura Health (ASX:VIT) has set the date for its annual meeting this week, putting its board in front of the register at a time when a dispute with health insurer Bupa over redirected telehealth patients threatens a meaningful slice of revenue at the cannabis and digital health group. The Meeting Notice Speciali...
Can Vitura Health Ltd (ASX:VIT) Stay on the Radar as Medical Cannabis Access and Healthcare Demand Take Centre Stage?
Highlights Sector rotation can become more pronounced when rates rise and risk appetite weakens. Vitura Health Ltd offers a live-session example of how cannabis shares can be read against that shift. The key question is whether regulatory execution and commercial discipline remains visible despite wider market noise. With global equities under pressure and bond markets resetting expectations, the Australian session begins with a stronger emphasis on selectivity. For Vitura Health Ltd (ASX:VIT...
Why Could Vitura Health (ASX:VIT) Face a Growth Reset?
Highlights Vitura Health enters the September session as higher bond yields create a more demanding environment for smaller growth-focused companies. Elevated oil prices, firmer yields and uneven sector leadership are adding complexity to the broader Australian share market. The healthcare distribution and digital platform remains sensitive to demand, operating execution, funding discipline and regulatory developments. The Australian share market is entering another closely watched session as...
Why Is Vitura Health (ASX:VIT) Facing a Tougher ASX Test?
Highlights Vitura Health enters the September market backdrop as healthcare demand meets tighter capital conditions. Elevated oil prices, firmer bond yields and uneven sector leadership are influencing the wider Australian sharemarket mood. Medicinal-cannabis exposure gives the healthcare business a distinct set of commercial, regulatory and funding considerations. Vitura Health (ASX:VIT) is entering a more complicated Australian sharemarket environment, where healthcare demand is being ...
Vitura Health faces $6m revenue hit after Bupa diverts telehealth patients to rival platform Hola
Digital health company Vitura Health (ASX: VIT) is bracing for a $6 million revenue hit after health insurer Bupa moved to redirect the majority of its telehealth patients away from Vitura's Doctors on Demand division to a competing platform in which Bupa holds a financial interest. Vitura has revealed that Bupa will redirect all internatio...
What Could Put Vitura Health (ASX:VIT) Back in Healthcare Stock Attention?
Highlights Attention around Vitura Health (ASX:VIT) is turning from headline expectations to the operating evidence likely to emerge from its full-year update. Against the the broader market setting, the more useful reading will come from how the business addresses patient volumes, product adoption, regulatory pathways and operating leverage. The next useful checkpoint for Vitura Health is whether its latest disclosure adds clearer evidence on execution, operating discipline and financial flexi...
What Does Vitura Health (ASX:VIT) Signal for Cannabis Stocks?
Highlights Attention around Vitura Health (ASX:VIT) is turning from headline expectations to the operating evidence likely to emerge from its latest scheduled market update. Against the [All Ordinaries] setting, the more useful reading will come from how the business addresses market access, portfolio breadth, manufacturing discipline and channel economics. The next useful checkpoint for Vitura Health is whether its latest disclosure adds clearer evidence on execution, operating discipline and ...
How Did Vitura Health (ASX:VIT) Reshape Its Cannabis Stocks Outlook?
Highlights For Australian equities, Vitura Health (ASX:VIT) brings a company-specific lens to a market still sorting through reporting-season signals. The [All Ordinaries] context matters, but the more useful reading will come from how the business addresses market access, portfolio breadth, manufacturing discipline and channel economics. The next useful checkpoint for Vitura Health is whether its latest disclosure adds clearer evidence on execution, operating discipline and financial flexibili...
Vitura Health Ltd (ASX:VIT) Faces Renewed Selling Pressure Amid Sector Headwinds - Kalkine
Vitura Health Ltd (ASX:VIT) Faces Renewed Selling Pressure Amid Sector Headwinds Kalkine
What Vitura Health’s (ASX:VIT) FY26 Results Reveal About Its Shift Towards Sustainable Growth? - Kalkine
What Vitura Health’s (ASX:VIT) FY26 Results Reveal About Its Shift Towards Sustainable Growth? Kalkine
What Could Vitura Health (ASX:VIT) Change for Cannabis?
Highlights The telehealth and dispensary group presented its full-year accounts to the market earlier this month via a webinar. Margin pressure from medicinal cannabis price compression and higher practitioner costs framed the interim result. Its general telehealth arm has passed a large consultation milestone and reached sustained profitability. The Australian market is treating the latest news from Vitura Health (ASX:VIT) as a test of business delivery rather than a standalone headline. Med...
What Is Vitura Health (ASX:VIT) Revealing About Cannabis?
Highlights Vitura Health is viewed through patient demand, product mix and distribution reach, keeping the discussion anchored to company-specific operating evidence. The Cannabis Stocks lens is used only as context; the article separates Vitura Health's business model from broader sector shorthand. Fresh disclosures around regulatory execution, cultivation efficiency and commercial scale are the most useful checkpoints for judging how the narrative is evolving. For Australian shares, the mor...
Why Vitura Health (ASX:VIT) Shares Are in Focus
Highlights An asset light distribution model has delivered profitability where cultivators have struggled. Regulatory review of prescribing and dispensing practices remains the sector's central variable. Marketplace economics scale with transaction volume rather than with production capacity. Vitura Health (ASX:VIT), the operator of a digital marketplace connecting authorised prescribers, pharmacies and suppliers across Australia's regulated medicinal cannabis segment, has stayed in market co...
ASX Cannabis Stocks: What Is Putting Vitura Health (ASX:VIT) in the Spotlight?
Highlights Vitura Health is in focus after a fresh company disclosure added new context to the public record. The cannabis stocks lens centres on regulated market access, product mix, distribution reach and cash discipline. The broader Australian market backdrop remains important when reading company-specific developments. Australian shares are being assessed against a shifting mix of company updates, sector conditions and global market signals, making fresh disclosures especially important f...
Can Vitura Health (ASX:VIT) Prove Platform Reach Commercial?
Highlights Vitura Health remains in focus as investors assess platform reach and commercial repair through product mix, a key indicator of whether current momentum can translate into durable operating progress. August reporting season is sharpening attention on manufacturing utilisation and channel economics, helping investors distinguish headline activity from the underlying quality of the business outlook. A key risk is that regulatory change can alter distribution economics, which could weak...
What Puts Vitura (ASX:VIT) Back On Penny Screens?
Highlights Vitura is drawing attention as smaller healthcare names are being filtered through revenue quality. Patient access, margin control and operating restraint shape the current ASX read. Little Green Pharma adds peer context as penny stocks face a stricter market screen. Vitura, a medicinal cannabis and digital health operator, is being pulled into a sharper Australian market conversation as smaller healthcare names are being filtered through revenue quality. Little Green Pharma (ASX:LG...
Vitura Health Limited Enhances Leadership with Strategic Appointments to Boost Patient-Centric Care
Vitura Health Limited has announced pivotal leadership appointments aimed at boosting operational efficiency and aligning its services more closely with patient needs. The addition of James Frayne as Chief Financial Officer and Trudy Adams as Executive General Manager of Strategy and Technology is set to advance the company’s strategic objectives and strengthen its digital health platform. Investors are likely to monitor how these leadership changes will shape Vitura's future trajectory. Key...
Can Vitura Health (ASX:VIT) Turn Telehealth Into Lasting Reach?
Highlights The medicinal cannabis and digital health group is scaling patient access through telehealth clinics. A connected model links patients, prescribers, pharmacists and suppliers across one ecosystem. Regulatory settings continue to shape the pace of growth for Australian cannabis names. One of the more established names in Australia's medicinal cannabis scene is leaning on telehealth to widen patient access and knit together the prescribing chain. Vitura Health (ASX:VIT), which builds...
Vitura Health (ASX:VIT) Offers a 6.66% Fully Franked Yield—What Should Income Investors Know? - Kalkine
Vitura Health (ASX:VIT) Offers a 6.66% Fully Franked Yield—What Should Income Investors Know? Kalkine
How Vitura (ASX:VIT) sits at the heart of cannabis distribution
Highlights Vitura Health kept attention as a distribution and telehealth platform in medicinal cannabis. Connecting prescribers, pharmacies and patients underpinned its role in the market. Rising prescription volumes shaped the backdrop for the sector's middlemen. Vitura Health (ASX:VIT), an Australian health-technology group that sits at the crossroads of medicinal cannabis prescribing and distribution, drew focus today as the market weighed the scale of its role connecting patients, prescribe...
Top Cannabis Stocks: Is Vitura Health (ASX:VIT) Channel Ready?
Highlights Vitura Health is drawing attention as digital healthcare and regulated patient access reshape the medicinal cannabis channel. Distribution reach, compliance discipline and cash conversion are becoming more important than broad sector enthusiasm. Market confidence increasingly depends on whether the company can connect patient demand with dependable commercial execution. Vitura Health remains in focus as digital healthcare, distribution reach, compliance discipline, cash convers...
Vitura Health Ltd (ASX: VIT) Moves Higher as Investors Reassess Healthcare Technology Opportunities - Kalkine
Vitura Health Ltd (ASX: VIT) Moves Higher as Investors Reassess Healthcare Technology Opportunities Kalkine
Why Is VIT Reshaping Cannabis Stocks Across the ASX?
Highlights Vitura Health is attracting renewed attention as regulated medicinal cannabis access becomes a key market theme. Operational execution, distribution discipline and cash flow quality are replacing broad sector optimism. The company's digital healthcare model is reinforcing its position within Australia's evolving medicinal cannabis industry. Australia's share market has entered the new trading week with investors carefully navigatin...
Why Is VIT Bringing Medicinal Cannabis Access Into Focus?
Highlights Vitura is attracting attention as patient access becomes a defining theme in Australia's medicinal cannabis sector. Platform trust and operational discipline remain central to the company's evolving story. Cash discipline continues shaping sentiment across the medicinal cannabis industry. Vitura remains a key medicinal cannabis company as patient access, platform trust and disciplined operations continue shaping Australia's evolv...
Vitura (ASX:VIT) and Zelira (ASX:ZLD): Why Cannabis Export Access Is Back in Focus
Highlights International export pathways are putting greater emphasis on compliance, manufacturing quality and commercial scale across the cannabis sector. Vitura Health (ASX:VIT) and Zelira Therapeutics (ASX:ZLD) highlight how different business models are shaping the latest sector narrative. The Australian market is increasingly rewarding companies with clearer execution, disciplined operations and identifiable business catalysts. ...
Vitura Health (ASX:VIT): Why Are ASX Cannabis Stocks Resetting?
Highlights ASX cannabis stocks are drawing fresh attention as cash discipline and funding resilience move back into focus. Zelira Therapeutics (ASX:ZLD) and Vitura Health show why company-specific proof matters more than sector labels. Current market focus is shifting toward regulated access, cash-flow quality and clearer operating catalysts. ASX cannabis stocks are drawing fresh attention a...
Vitura Health (ASX:VIT) and ASX 300 Cannabis Marketplace Expansion
Highlights Vitura Health upgraded revenue expectations while strengthening its marketplace-focused business model. The company operates a distribution platform connecting prescribers, pharmacies and third-party medicinal cannabis products. Distribution and patient access continue gaining attention across the Australian medicinal cannabis landscape. Vitura Health's marketplace model highlights the growing importance of distribution, healthcare access and pharmacy connectivity within Aust...
VIT enters distribution agreement with MedReleaf Australia
other announcement